Andrew D. Wiese, Ph.D.

Assistant Professor

andrew.d.wiese.1@vanderbilt.edu
Faculty Appointments
Assistant Professor of Health Policy
Education
Ph.D., Epidemiology, Vanderbilt University, Nashville, TennesseeM.P.H., Epidemiology, Saint Louis University, Saint Louis, MissouriB.S., Biology, Option in Microbiology/Cell Biology/Molecular/Biology/Biotechnology, Southeast Missouri State University , Cape Girardeau, Missouri
Office Address
Suite 2600, Village at Vanderbilt
1500 21st Avenue South
Nashville, TN 37027
Research Description
Andrew Wiese is an Assistant Professor in the Department of Health Policy at the Vanderbilt University School of Medicine. Dr. Wiese’s research interests include the characterization of unrecognized interactions and adverse outcomes associated with commonly used medications (including opioid analgesics and benzodiazepines), the design of pharmacoepidemiologic studies, and the evaluation of pharmaceutical and vaccine policies and programs.

Dr. Wiese is a current recipient of a Vanderbilt Faculty Research Scholars Award and a recipient of the PhRMA Foundation Postdoctoral Fellowship in Health Outcomes. He completed his postdoctoral training in the Division of Pharmacoepidemiology, Department of Health Policy at the Vanderbilt University School of Medicine. Dr. Wiese obtained his MPH from Saint Louis University, his PhD in Epidemiology from Vanderbilt University, and is a former CDC/CSTE Applied Epidemiology Fellow in the Healthcare-Associated Infections Program at the Tennessee Department of Health.
Research Keywords
Pharmacoepidemiology, Infectious Diseases, Pharmaceutical Policy
Publications
Wiese AD, Grijalva CG. To boost or not to boost? Lessons from the Australian pneumococcal conjugate vaccination program. Clin. Infect. Dis [print-electronic]. 2019 Aug 8/7/2019; PMID: 31388668, PII: 5544622, DOI: 10.1093/cid/ciz735, ISSN: 1537-6591.

Wiese AD, Griffin MR, Schaffner W, Stein CM, Greevy RA, Mitchel EF, Grijalva CG. Long-acting Opioid Use and the Risk of Serious Infections: A Retrospective Cohort Study. Clin. Infect. Dis. 2019 May 5/17/2019; 68(11): 1862-9. PMID: 30239630, PMCID: PMC6522680, PII: 5098443, DOI: 10.1093/cid/ciy809, ISSN: 1537-6591.

Wiese AD, Roumie CL, Buse JB, Guzman H, Bradford R, Zalimeni E, Knoepp P, Morris HL, Donahoo WT, Fanous N, Epstein BF, Katalenich BL, Ayala SG, Cook MM, Worley KJ, Bachmann KN, Grijalva CG, Rothman RL, Chakkalakal RJ. Performance of a computable phenotype for identification of patients with diabetes within PCORnet: The Patient-Centered Clinical Research Network. Pharmacoepidemiol Drug Saf [print-electronic]. 2019 May; 28(5): 632-9. PMID: 30680840, PMCID: PMC6615719, DOI: 10.1002/pds.4718, ISSN: 1099-1557.

Osmundson SS, Wiese AD, Min JY, Hawley RE, Patrick SW, Griffin MR, Grijalva CG. Delivery type, opioid prescribing, and the risk of persistent opioid use after delivery [letter]. Am. J. Obstet. Gynecol [print-electronic]. 2019 Apr; 220(4): 405-7. PMID: 30955527, PMCID: PMC6546169, PII: S0002-9378(18)30910-4, DOI: 10.1016/j.ajog.2018.10.026, ISSN: 1097-6868.

Wiese AD, Griffin MR, Grijalva CG. Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States. Expert Rev Vaccines [print-electronic]. 2019 Apr; 18(4): 327-41. PMID: 30759352, PMCID: PMC6443450, DOI: 10.1080/14760584.2019.1582337, ISSN: 1744-8395.

Wiese AD, Huang X, Yu C, Mitchel EF, Kyaw MH, Griffin MR, Grijalva CG. Changes in otitis media episodes and pressure equalization tube insertions among young children following introduction of the 13-valent pneumococcal conjugate vaccine: A birth-cohort based study. Clin. Infect. Dis [print-electronic]. 2019 Feb 2/16/2019; PMID: 30770533, PII: 5321113, DOI: 10.1093/cid/ciz142, ISSN: 1537-6591.

Wiese AD, Griffin MR, Schaffner W, Stein CM, Grijalva CG. Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases [letter]. Ann. Intern. Med. 2018 Sep 9/4/2018; 169(5): 355. PMID: 30178014, PII: 2698868, DOI: 10.7326/L18-0295, ISSN: 1539-3704.

Wiese AD, Griffin MR, Stein CM, Schaffner W, Greevy RA, Mitchel EF, Grijalva CG. Validation of discharge diagnosis codes to identify serious infections among middle age and older adults. BMJ Open. 2018 Jun 6/19/2018; 8(6): e020857. PMID: 29921683, PMCID: PMC6009457, PII: bmjopen-2017-020857, DOI: 10.1136/bmjopen-2017-020857, ISSN: 2044-6055.

Wiese AD, Grijalva CG. The use of prescribed opioid analgesics & the risk of serious infections [editorial]. Future Microbiol [print-electronic]. 2018 Jun 6/1/2018; 13: 849-52. PMID: 29896976, PMCID: PMC6060396, DOI: 10.2217/fmb-2018-0101, ISSN: 1746-0921.

Wiese AD, Griffin MR, Schaffner W, Stein CM, Greevy RA, Mitchel EF, Grijalva CG. Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases: A Nested Case-Control Study. Ann. Intern. Med [print-electronic]. 2018 Mar 3/20/2018; 168(6): 396-404. PMID: 29435555, PMCID: PMC6647022, PII: 2672601, DOI: 10.7326/M17-1907, ISSN: 1539-3704.

Wiese AD, Griffin MR, Zhu Y, Mitchel EF, Grijalva CG. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era. Vaccine [print-electronic]. 2016 Dec 12/7/2016; 34(50): 6243-9. PMID: 27832918, PMCID: PMC5552045, PII: S0264-410X(16)30997-5, DOI: 10.1016/j.vaccine.2016.10.062, ISSN: 1873-2518.

Wiese AD, Grijalva CG, Zhu Y, Mitchel EF, Griffin MR. Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines. Emerging Infect. Dis. 2016 Jun; 22(6): PMID: 27197048, PMCID: PMC4880071, DOI: 10.3201/eid2206.152023, ISSN: 1080-6059.

Wiese AD, Griffin MR, Stein CM, Mitchel EF, Grijalva CG. Opioid Analgesics and the Risk of Serious Infections Among Patients With Rheumatoid Arthritis: A Self-Controlled Case Series Study. Arthritis & rheumatology (Hoboken, N.J.). 2016 Feb; 68(2): 323-31. PMID: 26473742, PMCID: PMC4728045, DOI: 10.1002/art.39462, ISSN: 2326-5205.

Muleta D, Kainer MA, Moore-Moravian L, Wiese A, Ward J, McMaster S, Nguyen D, Forbi JC, Mixson-Hayden T, Collier M. Notes from the Field: Hepatitis C Outbreak in a Dialysis Clinic--Tennessee, 2014. MMWR Morb. Mortal. Wkly. Rep. 2016 Jan 1/1/2016; 64(50-51): 1386-7. PMID: 26720110, DOI: 10.15585/mmwr.mm6450a5, ISSN: 1545-861X.

Smith RM, Schaefer MK, Kainer MA, Wise M, Finks J, Duwve J, Fontaine E, Chu A, Carothers B, Reilly A, Fiedler J, Wiese AD, Feaster C, Gibson L, Griese S, Purfield A, Cleveland AA, Benedict K, Harris JR, Brandt ME, Blau D, Jernigan J, Weber JT, Park BJ, . Fungal infections associated with contaminated methylprednisolone injections. N. Engl. J. Med [print-electronic]. 2013 Oct 10/24/2013; 369(17): 1598-609. PMID: 23252499, DOI: 10.1056/NEJMoa1213978, ISSN: 1533-4406.

Kainer MA, Reagan DR, Nguyen DB, Wiese AD, Wise ME, Ward J, Park BJ, Kanago ML, Baumblatt J, Schaefer MK, Berger BE, Marder EP, Min JY, Dunn JR, Smith RM, Dreyzehner J, Jones TF, . Fungal infections associated with contaminated methylprednisolone in Tennessee. N. Engl. J. Med [print-electronic]. 2012 Dec 12/6/2012; 367(23): 2194-203. PMID: 23131029, PMCID: PMC4669562, DOI: 10.1056/NEJMoa1212972, ISSN: 1533-4406.